-
Location
-
North America
-
Europe
-
Latin America
-
Asia Pacific
- |
- Contact Us
- |
- Investors
- |
-
Location
-
North America
-
Europe
-
Latin America
-
Asia Pacific
- |
- Contact Us
- |
- Investors
- |
You are browsing the product catalog for
You are viewing the overview and resources for
Healthcare and Pharmaceuticals Packaging
From protecting medications to enabling next-generation respiratory therapies, Solstice Advanced Materials provides high-performance barrier films, medical fibers, and propellants that safeguard health and support better outcomes worldwide.
Pharmaceutical Packaging
Solstice Advanced Materials’ Aclar® film was developed in collaboration with medical, pharmaceutical, and other Med Tech companies to ensure peak barrier packaging performance. We are a proven packaging partner ready to support clients throughout all packaging phases, from design through production and launch. Aclar offers many different types of medication barrier film.
Aclar® film achieves the highest moisture barrier of any clear thermoplastic film, while processing within the same range as other thermoforming films. Whether you require mid, high, or ultra-high moisture barrier, there is an Aclar product available to provide the optimum balance of performance and economics.
Aclar’s medical and pharmaceutical packaging solutions protect the efficacy of life-saving medications and enable drug delivery around the world, enhancing the lives of patients globally.
Aclar®
High-barrier, thermoform film available in customizable thickness and sizes.
Aclar® Accel
A streamlined film portfolio with standardized options for faster production, cost efficiency, and sustainability benefits.
Respiratory Care
As many as 384 million people suffer from chronic obstructive pulmonary disease (COPD), a progressive respiratory disease, and 339 million children and adults suffer from asthma. Many of these patients are currently treated using pressurized metered dose inhalers (pMDIs) that use hydrofluorocarbons (HFCs), which contribute to the global carbon footprint of respiratory care. Solstice Air (HFO-1234ze(E) cGMP) is an alternative technology as a medical propellant, reducing the greenhouse gas emissions of pMDIs by up to 99.9% when compared to current inhaler propellants. Solstice Air is the only non-flammable, near-zero GWP propellant available and in clinical development today for pMDIs.
The future of metered dose inhalers (MDI) demands both technical excellence and environmental responsibility. Explore how Solstice® Air is transforming MDI technology through sustainable propellant solutions.
Solstice® Air
Medical-grade propellant for respiratory therapies. Trusted in:
- Metered-dose inhalers (MDIs)
- Asthma and COPD treatments
Pharmaceutical Packaging
Solstice Advanced Materials’ Aclar® film was developed in collaboration with medical, pharmaceutical, and other Med Tech companies to ensure peak barrier packaging performance. We are a proven packaging partner ready to support clients throughout all packaging phases, from design through production and launch. Aclar offers many different types of medication barrier film.
Aclar® film achieves the highest moisture barrier of any clear thermoplastic film, while processing within the same range as other thermoforming films. Whether you require mid, high, or ultra-high moisture barrier, there is an Aclar product available to provide the optimum balance of performance and economics.
Aclar’s medical and pharmaceutical packaging solutions protect the efficacy of life-saving medications and enable drug delivery around the world, enhancing the lives of patients globally.
Aclar®
High-barrier, thermoform film available in customizable thickness and sizes.
Aclar® Accel
A streamlined film portfolio with standardized options for faster production, cost efficiency, and sustainability benefits.
Respiratory Care
As many as 384 million people suffer from chronic obstructive pulmonary disease (COPD), a progressive respiratory disease, and 339 million children and adults suffer from asthma. Many of these patients are currently treated using pressurized metered dose inhalers (pMDIs) that use hydrofluorocarbons (HFCs), which contribute to the global carbon footprint of respiratory care. Solstice Air (HFO-1234ze(E) cGMP) is an alternative technology as a medical propellant, reducing the greenhouse gas emissions of pMDIs by up to 99.9% when compared to current inhaler propellants. Solstice Air is the only non-flammable, near-zero GWP propellant available and in clinical development today for pMDIs.
The future of metered dose inhalers (MDI) demands both technical excellence and environmental responsibility. Explore how Solstice® Air is transforming MDI technology through sustainable propellant solutions.
Solstice® Air
Medical-grade propellant for respiratory therapies. Trusted in:
- Metered-dose inhalers (MDIs)
- Asthma and COPD treatments
Maximum File Size
Maximum Files Exceeded
Due to inactivity you will be logged out in 000 seconds.
Maximum File Size
Maximum Files Exceeded
Honeywell International Inc. is committed to ensuring compliance with global laws that regulate its export and import activities. In following company procedures, it has been determined that is identified on a denied/restricted parties list that is applicable to this transaction.
As a result, Honeywell is unable to continue with this request.
CONTACT US
We’re here if you need us. Complete the form to connect with our team on any inquiry, including outreach to our sales or customer experience teams, tips on and troubleshooting with your portal or ecommerce profile, and to sign up for marketing communications.
Solstice Advanced Materials Inc.
115 Tabor Rd,
Morris Plains, NJ 07950
Copyright © 2025 Solstice Advanced Materials Inc.